CoChat

Protective Effects and Molecular Signaling of n-3 Fatty Acids on Oxidative Stress and Inflammation in Retinal Diseases

Open access
Suzumura, Ayana, Terao, Ryo, Kaneko, Hiroki · 2020 · Antioxidants

The DOI matches its Crossref record; 246 of the 252 references it cites were found in a registry or an index.

Abstract

Oxidative stress and inflammation play crucial roles in the development and progression of retinal diseases. Retinal damage by various etiologies can result in retinopathy of prematurity (ROP), diabetic retinopathy (DR), and age-related macular degeneration (AMD). n-3 fatty acids are essential fatty acids and are necessary for homeostasis. They are important retinal membrane components and are involved in energy storage. n-3 fatty acids also have antioxidant and anti-inflammatory properties, and their suppressive effects against ROP, DR, and AMD have been previously evaluated. α-linolenic acid (ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and their metabolites have been shown to alleviate retinal oxidative stress and inflammation involving various biological signaling pathways. In this review, we summarize the current understanding of the n-3 fatty acids effects on the mechanisms of these retinal diseases and how they exert their therapeutic effects, focusing on ALA, EPA, DHA, and their metabolites. This knowledge may provide new remedial strategies for n-3 fatty acids in the prevention and treatment of retinal diseases associated with oxidative stress and inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antiox9100920

Cites

246 of 246 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 n-3 fatty acids are metabolized to specialized proresolving mediators (SPMs).
Figure 1 n-3 fatty acids are metabolized to specialized proresolving mediators (SPMs).CC BY · PubMed Central
Figure 2 Schematic representation of the inhibitory effects of n-3 fatty acids and specialized proresolving mediator (SPM) on reactive oxygen species (ROS) and inflammation. Black: α-linolenic acid (ALA), Blue: docosahexaenoic acid (DHA) and its metabolites, Green: eicosapentaenoic acid (EPA) and its metabolites, Red: n-3 fatty acids.
Figure 2 Schematic representation of the inhibitory effects of n-3 fatty acids and specialized proresolving mediator (SPM) on reactive oxygen species (ROS) and inflammation. Black: α-linolenic acid (ALA), Blue: docosahexaenoic acid (DHA) and its metabolites, Green: eicosapentaenoic acid (EPA) and its metabolites, Red: n-3 fatty acids.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Items 201–246 of 246

Cited by

See all 46

Metadata

Authors
Suzumura, A., Terao, R., & Kaneko, H.
Affiliations
  • Nagoya University (JP)
  • The University of Tokyo (JP)
Corresponding author
Kaneko, Hiroki
Venue
Antioxidants
Publisher
MDPI AG
Published
2020-09-26
Volume
9
Issue
10
Pages
920
ISSN
2076-3921 (ISSN-L)
OpenAlex
W3088710303
Cited by
44
References
252
Citations by year
2026: 5 · 2025: 9 · 2024: 5 · 2023: 5 · 2022: 9 · 2021: 11
FWCI
0.77
Type
journal article
Language
en
Open access
Locations
  • Antioxidants (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ichihara International Scholarship Foundation
  • Santen
  • Japan Society for the Promotion of Science (19K09988)
  • European Regional Development Fund
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
Keywords
omega-3 fatty acids, retinal disease, oxidative stress, inflammation, retinopathy of prematurity, diabetic retinopathy, age-related macular degeneration, alpha-linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, fatty acid metabolites, antioxidant activity, anti-inflammatory activity, molecular pathways

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.